NCT05472012Completed
Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)
Source: ClinicalTrials.gov · Last updated 22 May 2025
Brief summary (registry, in English)
This study is designed to validate the performance of Masimo INVSENSOR00057 in detecting atrial fibrillation. The noninvasive ECG measurements will be compared to results obtained from an FDA-cleared ECG monitor.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 139 (actual)
- First submitted
- 21 Jul 2022
- Start date
- 25 Jul 2022
- Primary completion date
- 16 Dec 2023
- Lead sponsor
- Masimo Corporation
- Diseases
- Atrial fibrillation
- NCT number
- NCT05472012
What you commit to
- Study type: Interventional
- Participants enrolled: 139
- From 25 Jul 2022 to the primary completion date, 16 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subject is confirmed to have concurrent active arrhythmias (e.g., PVCs, bradycardia, etc.) at the time of enrollment.
Other illness
- Subject is allergic to adhesives or ECG gel.
Other
- Subject whose skin is not intact in or at the vicinity of the device placement site.
Who the study is looking for
- Subject is 18 years of age or older.
- Subject is confirmed to have active atrial fibrillation at the time of enrollment.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Site 1 Coordinator of this site? Confirm its status | Jackson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.